Microbix Biosystems Inc. (TSX:MBX)
Canada · Delayed Price · Currency is CAD 0.2500
0.00 (0.00%)
At close: Mar 20, 2026
Microbix Biosystems Market Cap
Microbix Biosystems has a market cap or net worth of CAD 34.56 million as of March 20, 2026. Its market cap has decreased by -38.92% in one year.
Market Cap
34.56M
Enterprise Value
32.33M
Revenue
16.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
Market Cap Chart
Since October 1, 1992, Microbix Biosystems's market cap has increased from 13.38M to 34.56M, an increase of 158.28%. That is a compound annual growth rate of 2.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 20, 2026 | 34.56M | 8.12% |
| Dec 31, 2025 | 31.97M | -41.99% |
| Dec 31, 2024 | 55.10M | 3.47% |
| Dec 29, 2023 | 53.25M | -6.55% |
| Dec 30, 2022 | 56.99M | -47.62% |
| Dec 31, 2021 | 108.80M | 135.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NurExone Biologic | 58.87M |
| Medicenna Therapeutics | 58.39M |
| Sernova Biotherapeutics | 52.16M |
| MedMira | 45.33M |
| Defence Therapeutics | 43.09M |
| BriaCell Therapeutics | 41.33M |
| Resverlogix | 34.78M |
| Devonian Health Group | 34.30M |